ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,866Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 97

$658K Total Retail Price of All Prescriptions

Rank: 17 out of 97

766 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 766 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 766 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 10,328 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 501 464 1 1
SIMVASTATIN 470 427 2 2
HYDROCODONE-ACETAMINOPHEN 457 302 S3 3 17
LISINOPRIL 425 388 4 4
AMLODIPINE BESYLATE 345 323 5 6
HYDROCHLOROTHIAZIDE 324 297 6 9
FUROSEMIDE 322 307 7 3
WARFARIN SODIUM 314 288 8 11
OMEPRAZOLE 301 273 9 5
METOPROLOL TARTRATE 294 286 10 7
METOPROLOL SUCCINATE 241 241 11 8
TRAMADOL HCL 220 168 12 21
ALENDRONATE SODIUM 186 176 13 19
POTASSIUM CHLORIDE 184 163 14 10
METFORMIN HCL 181 155 15 12
ATENOLOL 171 160 16 15
ATORVASTATIN CALCIUM 144 128 17 14
CITALOPRAM HBR 138 127 18 20
GABAPENTIN 123 109 19 18
ZOLPIDEM TARTRATE 121 102 20 32
PREDNISONE 118 107 21 23
CARVEDILOL 110 97 22 25
DIGOXIN 107 93 23 26
SERTRALINE HCL 103 81 24 16
FLUOXETINE HCL 99 84 25 63
ALLOPURINOL 96 85 26 22
MIRTAZAPINE 82 77 27 35
CLOPIDOGREL 80 73 28 34
NOVOLOG FLEXPEN 76 75 29 74
CIPROFLOXACIN HCL 75 67 30 60
LOSARTAN-HYDROCHLOROTHIAZIDE 75 72 30 49
FLUTICASONE PROPIONATE 72 70 32 52
DIOVAN 72 71 32 44
FENTANYL 71 42 S2 34 50
LANTUS 71 62 34 43
FINASTERIDE 70 70 36 58
ROPINIROLE HCL 68 65 37 98
LIOTHYRONINE SODIUM 67 60 38 160
TAMSULOSIN HCL 66 65 39 31
TRAZODONE HCL 65 53 40 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 59 40 36
ADVAIR DISKUS 64 58 42 40
POLYETHYLENE GLYCOL 3350 64 53 42 55
PANTOPRAZOLE SODIUM 60 45 44 53
DONEPEZIL HCL 59 57 45 24
DILTIAZEM ER 58 43 46 85
GLIMEPIRIDE 57 46 47 39
LOSARTAN POTASSIUM 56 43 48 13
TRIAMCINOLONE ACETONIDE 55 49 49 110
AMLODIPINE BESYLATE-BENAZEPRIL 55 49 49 148
AZITHROMYCIN 54 43 51 64
DOXAZOSIN MESYLATE 54 42 51 45
SPIRONOLACTONE 53 42 53 33
CRESTOR 52 37 54 29
QUETIAPINE FUMARATE 52 52 54 82
PLAVIX 51 44 56 46
KLOR-CON M20 50 30 57 92
JANTOVEN 50 50 57 37
JANUVIA 50 36 57 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.